IMPACT-core's main goal is to coordinate the implementation of functional precision cancer medicine, which includes all the steps for developing pre-clinical models and sample processing for downstream molecular analysis.
Our services include:
- DNA/RNA sample processing and Quality Control (Fresh Frozen and FFPE)
- Establish patient-derived tumor Organoid (PDO), Xenograft (PDX) models, and cell lines
- Multiplex tumor and immune microenvironment evaluation
- Drug testing on Patient-Derived models and ex-vivo patient tumors.
* The establishment attempt of patient-derived models is solely for patients participating in biobanks with approved Research Ethics Board (REB). Please contact the core for more information.
Fees
Description
|
Price / Sample
Internal (GCI)
|
Price / Sample
McGill Partners
|
Price / Sample Academia |
Price / Sample Industry |
| DNA/RNA extraction and Quality Control (per patient, Tumor, and Normal samples) – Fresh Frozen |
$100 |
$160 |
$210 |
$250 |
| DNA/RNA extraction and Quality Control (per patient, Tumor, and Normal samples) – Formalin-Fixed Parafrin-Embedded (FFPE) |
$120 |
$200 |
$260 |
$340 |
| Multiplex evaluation for immune and cancer markers panels (18 markers) |
$1000 |
$1600 |
$2100 |
$2800 |
| PDX Model establishment |
$4200/attempt ** |
$5500/attempt ** |
$7200/attempt ** |
- |
| In vitro model establishment (Cell lines and Organoids) |
$2000/attempt |
$2300/attempt |
$3000/attempt |
- |
| Ex-vivo experiment set up for drug testing |
$2500 *** |
$3250 *** |
$4250*** |
- |
| Drug testing on Patient-Derived models |
Custom |
Custom |
Custom |
- |
**Engraftment of 4 mice (one cage) + 6 months of mouse house/monitoring
*** Depending on tumor size
Additional prices can apply